Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Coeptis Therapeutics Holdings, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
Revenues0.00.00.0
Cost of goods sold0.70.10.0
Gross profit-0.7-0.10.0
Selling, general and administrative0.00.00.0
EBIT-0.7-0.10.0
Pre-tax income15.2-17.30.0
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income15.2-17.30.0
 
Diluted EPS$2.03($14.50)$0.00
Shares outstanding (diluted)7.51.21.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy